Engeneic Is A Clinical Stage Biopharmaceutical Company Based In Sydneyaustraliaspecializing In Immuno Oncologythe Company Is Dedicated To Developing Innovative Cancer Treatments Through Its Proprietary Edva Cengeneic Dream Vectornanocell Technologythis Technology Is Designed To Target Tumors Directly And Harness The Patient S Immune System To Fight Cancer The Primary Focus Of Engeneic Is The Advancement Of Its Cancer Immunotherapy Platformwhich Utilizes Engineered Bacterial Minicells To Deliver Therapeutic Payloads Directly To Cancer Cellsthis Targeted Approach Aims To Enhance Treatment Effectiveness And Stimulate The Immune Response Against Cancerengeneic S Product Pipeline Includes The Edva C Nanocell Technologywhich Offers A Novel Method For Delivering Drugs And Genetic Material To Improve Patient Outcomes Across Various Cancer Types Engeneic Has Partnered With Biocina To Further Develop Its Technology And Has Received Early Stage Venture Capital Fundingindicating Strong Support For Its Innovative Approach In The Biopharmaceutical Industry
No conferences found for this company.
| Company Name | Engeneic Pty Ltd |
| Country |
Australia
|
| Address | N/A |
| Telephone | N/A |
| N/A |
